|
|
Volumn 70, Issue 2, 2014, Pages 249-250
|
|
Dabigatran and rivaroxaban prescription for atrial fibrillation in Catalonia, Spain: The need to manage the introduction of new drugs
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
ANTIVITAMIN K;
APIXABAN;
CREATININE;
CYCLOSPORIN;
DABIGATRAN;
DRONEDARONE;
ITRACONAZOLE;
KETOCONAZOLE;
RIVAROXABAN;
TACROLIMUS;
VERAPAMIL;
ANTICOAGULANT THERAPY;
CLINICAL TRIAL (TOPIC);
CREATININE CLEARANCE;
FOLLOW UP;
HEART ATRIUM FIBRILLATION;
HUMAN;
INTERNATIONAL NORMALIZED RATIO;
KIDNEY FUNCTION;
LETTER;
MEDICAL DECISION MAKING;
PRESCRIPTION;
PRIORITY JOURNAL;
RECOMMENDED DRUG DOSE;
SPAIN;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTICOAGULANTS;
ATRIAL FIBRILLATION;
BENZIMIDAZOLES;
BETA-ALANINE;
DRUG UTILIZATION;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MORPHOLINES;
PHYSICIAN'S PRACTICE PATTERNS;
SPAIN;
THIOPHENES;
|
|
EID: 84893223979
PISSN: 00316970
EISSN: 14321041
Source Type: Journal
DOI: 10.1007/s00228-013-1593-6 Document Type: Letter |
|
Times cited : (20)
|
|
References (4)
|
